Literature DB >> 30691289

Synthesis of new boswellic acid derivatives as potential antiproliferative agents.

Umair Shamraiz1,2, Hidayat Hussain1,3, Najeeb Ur Rehman1, Sulaiman Al-Shidhani1, Aasim Saeed1,2, Husain Yar Khan1, Ajmal Khan1, Lucie Fischer4, René Csuk4, Amin Badshah2, Ahmed Al-Rawahi1, Javid Hussain1, Ahmed Al-Harrasi1.   

Abstract

In the current investigation, a series of heterocyclic derivatives of boswellic acids were prepared along with new monomers of 3-O-acetyl-11-keto-β-boswellic acid (AKBA, 1) 11-keto-β-boswellic acid (KBA, 2) and several new bis-AKBA and KBA homodimers and AKBA-KBA heterodimers. The effects of these compounds on the proliferation of different human cancer cell lines, viz., FaDu (pharynx carcinoma), A2780 (ovarian carcinoma), HT29 (colon adenocarcinoma), and A375 (malignant melanoma), have been evaluated. Thus, KBA homodimer 21 effectively inhibited the growth of FaDu, A2780, HT29, and A375 cells with EC50 values below 9 μM. In addition, compounds 7, 8, 11, 12, 15, 16, and 17 also exhibited cytotoxic effects for A2780, HT29, and A375 cancer cells. In particular, the pyrazine analog 8 was highly cytotoxic for A375 cancer cells with an EC50 value of 2.1 μM.

Entities:  

Keywords:  AKBA-KBA heterodimers; Boswellic acid; cytotoxicity

Mesh:

Substances:

Year:  2019        PMID: 30691289     DOI: 10.1080/14786419.2018.1564295

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  2 in total

1.  Synthesis of 3-O-Acetyl-11-keto-β-boswellic Acid (AKBA)-Derived Amides and Their Mitochondria-Targeted Antitumor Activities.

Authors:  Changhao Li; Qiaobian He; Yuwen Xu; Hongxiang Lou; Peihong Fan
Journal:  ACS Omega       Date:  2022-03-07

2.  Evaluation of the Anti-Atopic Dermatitis Effects of α-Boswellic Acid on Tnf-α/Ifn-γ-Stimulated HaCat Cells and DNCB-Induced BALB/c Mice.

Authors:  Ya-Chu Tsai; Hsun-Hao Chang; Sheng-Chieh Chou; Thomas W Chu; Yu-Jou Hsu; Chien-Yu Hsiao; Yuan-Hsin Lo; Nan-Lin Wu; Der-Chen Chang; Chi-Feng Hung
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.